THE INTERACTION BETWEEN ENDOTHELIUM-DERIVED RELAXING FACTOR (EDRF) AND EICOSANOIDS IN THE REGULATION OF THE MESENTERIC MICROCIRCULATION

被引:8
|
作者
KODAMA, T [1 ]
MARMON, LM [1 ]
VARGAS, R [1 ]
FARHAT, M [1 ]
HOY, GR [1 ]
RAMWELL, PW [1 ]
机构
[1] GEORGETOWN UNIV, SCH MED, DEPT PHYSIOL & BIOCHEM, WASHINGTON, DC 20007 USA
关键词
D O I
10.1006/jsre.1995.1035
中图分类号
R61 [外科手术学];
学科分类号
摘要
Locally produced eicosanoids and endothelium-derived factors are believed to be the mediators of vascular tone of various vascular beds including the mesentery. Using a small vessel isometric myograph which allows direct measurement of microvascular reactivity, the interaction of eicosanoids and endothelium-derived relaxing factor (EDRF) in regulating vascular tone of mesenteric microcirculation of the rat was characterized. The microvascular response to various vasoactive agents before and after inhibition of prostacyclin production with indomethacin (INDO, 5 mu M) and inhibition of EDRF synthesis with N omega-nitro-L-arginine methyl ester (L-NAME, 50 mu M) was compared. Analysis of dose-response curves for prostaglandin F-2 alpha (PGF(2 alpha)), U46619, a stable thromboxane analog, and norepinephrine (NE) after pretreatment with INDO demonstrated that inhibition of endogenous eicosanoids significantly attenuated the vasoconstrictor response to PGF(2 alpha) and U46619 but not to NE. Inhibition of EDRF synthesis with L-NAME potentiated the vaso-constrictor response to PGF(2 alpha), U46619, and NE. These results suggest that EDRF acts as the primary mediator of vasodilator tone in the mesenteric microcirculation rather than vasodilator cyclooxygenase products such as prostacyclin. It also appears that the vasoconstrictor action of PGF(2 alpha) and U46619 may be mediated by a release of an endogenous indomethacin-sensitive factor. (C) 1995 Academic Press, Inc.
引用
收藏
页码:227 / 232
页数:6
相关论文
共 50 条
  • [1] ENDOTHELIUM-DERIVED RELAXING FACTOR (EDRF)
    GRIFFITH, TM
    PHYSIOLOGIA BOHEMOSLOVACA, 1987, 36 (06): : 576 - 576
  • [2] ENDOTHELIUM-DERIVED RELAXING FACTOR (EDRF)
    MURRAY, JJ
    BIOPHYSICAL JOURNAL, 1990, 57 (02) : A12 - A12
  • [3] ENDOTHELIUM-DERIVED RELAXING FACTOR (EDRF)
    TODA, N
    OKAMURA, T
    FOLIA PHARMACOLOGICA JAPONICA, 1990, 95 (06) : 295 - 308
  • [4] ENDOTHELIUM-DERIVED RELAXING FACTOR (EDRF)
    DEFEUDIS, FV
    AGENTS AND ACTIONS, 1985, 17 (02): : 181 - 183
  • [5] FORMATION AND FUNCTIONAL IMPORTANCE OF ENDOTHELIUM-DERIVED RELAXING FACTOR (EDRF) AND PROSTAGLANDINS IN THE MICROCIRCULATION
    FORSTERMANN, U
    WARMUTH, G
    DUDEL, C
    ALHEID, U
    ZEITSCHRIFT FUR KARDIOLOGIE, 1989, 78 : 85 - 91
  • [6] Endothelium-derived relaxing factor (EDRF)-mediated vasodilation in mice mesenteric arteries
    Wake, Yoshihiro
    Makino, Kento
    Fujiwara, Hiroki
    Hashikawa, Narumi
    Hashikawa, Naoya
    Takatori, Shingo
    Kawasaki, Hiromu
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2011, 115 : 156P - 156P
  • [7] THE ROLE OF ENDOTHELIUM-DERIVED RELAXING FACTOR (EDRF) IN THE REGULATION OF DIAPHRAGMATIC ENERGETICS
    CHANG, H
    WARD, ME
    HUSSAIN, SNA
    FASEB JOURNAL, 1992, 6 (04): : A1178 - A1178
  • [8] CLINICAL RELEVANCE OF ENDOTHELIUM-DERIVED RELAXING FACTOR (EDRF)
    BASSENGE, E
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1992, 34 : S37 - S42
  • [9] CELLULAR EFFECTS OF ENDOTHELIUM-DERIVED RELAXING FACTOR (EDRF)
    KUKOVETZ, WR
    HOLZMANN, S
    INTERNATIONAL JOURNAL OF MICROCIRCULATION-CLINICAL AND EXPERIMENTAL, 1986, 5 (2-3): : 167 - 167
  • [10] IS THERE AN ABLUMINAL RELEASE OF ENDOTHELIUM-DERIVED RELAXING FACTOR (EDRF)
    VEDERNIKOV, YP
    GRASER, T
    TIEDT, N
    BASIC RESEARCH IN CARDIOLOGY, 1987, 82 (02) : 172 - 177